SG11201509367RA - Methods for predicting and improving the survival of colorectal cancer patients - Google Patents

Methods for predicting and improving the survival of colorectal cancer patients

Info

Publication number
SG11201509367RA
SG11201509367RA SG11201509367RA SG11201509367RA SG11201509367RA SG 11201509367R A SG11201509367R A SG 11201509367RA SG 11201509367R A SG11201509367R A SG 11201509367RA SG 11201509367R A SG11201509367R A SG 11201509367RA SG 11201509367R A SG11201509367R A SG 11201509367RA
Authority
SG
Singapore
Prior art keywords
predicting
survival
improving
methods
colorectal cancer
Prior art date
Application number
SG11201509367RA
Other languages
English (en)
Inventor
Phillip Kim
Anjali Jain
Sharat Singh
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201509367RA publication Critical patent/SG11201509367RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/14—Post-translational modifications [PTMs] in chemical analysis of biological material phosphorylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/54—Determining the risk of relapse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201509367RA 2013-05-21 2014-05-21 Methods for predicting and improving the survival of colorectal cancer patients SG11201509367RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361825998P 2013-05-21 2013-05-21
PCT/IB2014/061606 WO2014188363A1 (en) 2013-05-21 2014-05-21 Methods for predicting and improving the survival of colorectal cancer patients

Publications (1)

Publication Number Publication Date
SG11201509367RA true SG11201509367RA (en) 2015-12-30

Family

ID=50896377

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201509367RA SG11201509367RA (en) 2013-05-21 2014-05-21 Methods for predicting and improving the survival of colorectal cancer patients

Country Status (10)

Country Link
US (1) US9903867B2 (ko)
EP (2) EP3373010A1 (ko)
JP (1) JP6478417B2 (ko)
KR (1) KR20160009070A (ko)
AU (1) AU2014269946A1 (ko)
CA (1) CA2912989A1 (ko)
HK (1) HK1223156A1 (ko)
MX (1) MX2015016065A (ko)
SG (1) SG11201509367RA (ko)
WO (1) WO2014188363A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102332655B1 (ko) * 2020-05-18 2021-11-30 고려대학교 산학협력단 대장암 예후 예측용 마커 및 이의 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532138A (en) 1990-04-26 1996-07-02 Behringwerke Ag Method and kits for determining peroxidatively active catalysts
US5332662A (en) 1992-07-31 1994-07-26 Syntex (U.S.A.) Inc. Methods for determining peroxidatively active substances
ATE177842T1 (de) 1993-09-03 1999-04-15 Behringwerke Ag Fluoreszenz-sauerstoffkanalisation-immunteste
US20040229294A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
CA2521106A1 (en) * 2003-04-01 2004-10-14 Monogram Biosciences, Inc. Intracellular complexes as biomarkers
EP2064549B1 (en) 2006-09-21 2012-10-24 Prometheus Laboratories, Inc. Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
AU2008276251B2 (en) 2007-07-13 2014-04-24 Nestec S.A. Drug selection for lung cancer therapy using antibody-based arrays
NZ600339A (en) 2008-02-25 2013-12-20 Nestec Sa Drug selection for breast cancer therapy using antibody-based arrays
US8396228B2 (en) 2008-02-27 2013-03-12 Stethoscope Technologies, Inc. Floating ballast mass active stethoscope or sound pickup device
US8137919B2 (en) * 2008-04-10 2012-03-20 Montefiore Medical Center Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
NZ616755A (en) 2009-05-14 2015-05-29 Nestec Sa Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
AU2010310746B2 (en) 2009-10-20 2015-07-23 Nestec S.A. Proximity-mediated assays for detecting oncogenic fusion proteins
US20120231965A1 (en) * 2011-02-03 2012-09-13 Prometheus Laboratories Inc. Drug selection for colorectal cancer therapy using antibody-based arrays
EP2681552A2 (en) * 2011-03-02 2014-01-08 Nestec S.A. Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures

Also Published As

Publication number Publication date
KR20160009070A (ko) 2016-01-25
EP2999966A1 (en) 2016-03-30
EP2999966B1 (en) 2018-04-25
MX2015016065A (es) 2016-03-21
EP3373010A1 (en) 2018-09-12
JP6478417B2 (ja) 2019-03-06
JP2016520198A (ja) 2016-07-11
US20160169898A1 (en) 2016-06-16
HK1223156A1 (zh) 2017-07-21
AU2014269946A1 (en) 2015-12-03
US9903867B2 (en) 2018-02-27
WO2014188363A1 (en) 2014-11-27
CA2912989A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and preparations for the treatment of cancer
HK1216991A1 (zh) 癌疫苗及使用其的治療方法
HK1220110A1 (zh) 治療肺癌的方法
SG10201801965RA (en) Treatment of cancer with dihydropyrazino-pyrazines
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
HK1219489A1 (zh) 治療結腸直腸癌的方法
HK1213817A1 (zh) 治療癌症的方法
ZA201604370B (en) Prostate cancer gene profiles and methods of using the same
HK1225967A1 (zh) IFN-γ與抗-ERBB抗體的結合物用於治療癌症
HK1223844A1 (zh) 用於管理癌症和治療癌症並存病的方法
HK1219513A1 (zh) 治療癌症的方法
IL244632A0 (en) Cancer biomarker and diagnostics
HK1223547A1 (zh) 癌症治療方法
EP3003371A4 (en) MATERIALS AND METHODS FOR THE TREATMENT OF LIVER CANCER
LT2984108T (lt) Anti-s100a7 antikūnai, skirti vėžio gydymui ir diagnozei
HK1215390A1 (zh) 結直腸癌的模型
HK1213475A1 (zh) 用於癌症治療的 、卡培他濱和奧沙利鉑的組合
HK1223156A1 (zh) 用於預測和改進結腸直腸癌患者的存活的方法
EP3050975A4 (en) Method for predicting the response to chemotherapy treatment in patients suffering from colorectal cancer
GB2519829B (en) Methods for monitoring treatment response and relapse in breast cancer
PL3016948T3 (pl) 2-acyloaminotiazole do leczenia nowotworów
HK1214502A1 (zh) 用於癌症治療的 和卡培他濱的組合
GB201302884D0 (en) Novel methods for diagnosis and therapy